Novo Nordisk licenses 'small antibody' tech from Ablynx
Ablynx has licensed its nanobody platform to Novo Nordisk which hopes to discover and develop single-domain antibody fragment drug candidates.
Archives for November 25, 2015
Reprocell buys into cell therapy discovery services sector with Biopta takeover
Reprocell has entered the CRO space through the acquisition of preclinical discovery services Biopta.